1. Home
  2. RVLV vs KLRA Comparison

RVLV vs KLRA Comparison

Compare RVLV & KLRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Revolve Group Inc.

RVLV

Revolve Group Inc.

N/A

Current Price

$18.78

Market Cap

1.5B

ML Signal

N/A

Logo Kailera Therapeutics Inc. Common Stock

KLRA

Kailera Therapeutics Inc. Common Stock

N/A

Current Price

$13.02

Market Cap

1.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RVLV
KLRA
Founded
2003
2024
Country
United States
United States
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.7B
IPO Year
2018
2026

Fundamental Metrics

Financial Performance
Metric
RVLV
KLRA
Price
$18.78
$13.02
Analyst Decision
Buy
Strong Buy
Analyst Count
15
6
Target Price
$30.31
★ $42.75
AVG Volume (30 Days)
819.5K
★ 1.1M
Earning Date
11-03-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 24.64
N/A
EPS
★ 0.66
N/A
Revenue
★ $1,225,682,000.00
N/A
Revenue This Year
$14.43
N/A
Revenue Next Year
$8.74
N/A
P/E Ratio
$30.27
★ N/A
Revenue Growth
★ 8.48
N/A
52 Week Low
$17.35
$9.76
52 Week High
$31.68
$23.82

Technical Indicators

Market Signals
Indicator
RVLV
KLRA
Relative Strength Index (RSI) 30.19 54.48
Support Level $17.91 $9.76
Resistance Level $23.98 $13.83
Average True Range (ATR) 1.22 0.90
MACD -0.43 0.09
Stochastic Oscillator 13.46 72.08

Price Performance

Historical Comparison
RVLV
KLRA

About RVLV Revolve Group Inc.

Revolve Group Inc is an emerging e-commerce retailer, selling women's dresses, handbags, shoes, beauty products, and incidentals across its marketplace properties, Revolve and FWRD. The platform is built to suit the "next-generation customer," emphasizing mobile commerce, influencer marketing, and occupying an aspirational but attainable luxury niche. With $1.1 billion in 2024 net sales, the firm sits just outside the top 30 apparel retailers (by sales) in the U.S, but has consistently generated robust top-line growth as the industry continues to favor digital channels. Revolve generates approximately 18% of sales from private-label offerings, while focusing on building an inventory of distinctive products from emerging fashion brands with less than $10 million in annual sales.

About KLRA Kailera Therapeutics Inc. Common Stock

Kailera Therapeutics Inc is a clinical-stage biotechnology company. The company focuses on developing a diversified pipeline to provide options for people living with obesity. The company is progressing four clinical-stage product candidates, leveraging multiple GLP-1 based mechanisms of action and routes of administration. The company's obesity-first approach seeks to advance product candidates with the potential to maximize weight loss and address critical needs in the current therapeutic landscape.

Share on Social Networks: